Moreover, RANKL acts as a chemoattractant to M2 macrophages and tumour cells [6,37] and the RANK pathway is involved in epithelial–mesenchymal transition (EMT) and stemness, and facilitates tumour growth and metastasis by modulating immune and vascular niches [38]. The gene discussed is TNFRSF11A; the disease is neoplasm.